Expression levels of EXO1 vary across different cancers; for instance, it is elevated in certain tumors such as lung adenocarcinoma (17), breast cancer (18), and hepatocellular carcinoma (19), while reduced in others like neuroblastoma (20) and leukemia (21). The gene discussed is EXO1; the disease is lung adenocarcinoma.